failure to respond or late response
on 09 Nov 2020
Last Applicant/ Owned by
9805 Burgen Ave
Los Angeles
CA
90048
Serial Number
88107543 filed on 06th Sep 2018
Registration Number
N/A
Correspondent Address
Chelsea Carbone
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"BIOTECH"
The mark consists of "GEMELLI BIOTECH" in black stylized font appearing the right of the letters "GB" in stylized white font within a black circle. The center of the letter "G" and the center of the letter "B" in "GB" are purple and pink circles, respectively. The color(s) black, white, purple and pink is/are claimed as a feature of the mark. Medical testing for diagnostic or treatment purposes;Read More
Medical testing for diagnostic or treatment purposes; providing medical information to physicians, patients, researchers, and medical professionals in the form of reports in the field of medical diagnostics, clinical diagnostics, medical research, clinical research, drug development, drug development research, biotechnology, and genetics
31st Oct 2018
31st Oct 2018
No 88107543
No Service Mark
No 56112-TM1002
No
No
No
No
No
No
No
No
26.01.21 -
Circles that are totally or partially shaded
The mark consists of "GEMELLI BIOTECH" in black stylized font appearing the right of the letters "GB" in stylized white font within a black circle. The center of the letter "G" and the center of the letter "B" in "GB" are purple and pink circles, respectively.
| Status Date | Action Taken |
|---|---|
| 09th Nov 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 09th Nov 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 28th Apr 2020 | SU - FINAL REFUSAL - WRITTEN |
| 28th Apr 2020 | FINAL REFUSAL E-MAILED |
| 28th Apr 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 20th Apr 2020 | TEAS EXTENSION RECEIVED |
| 10th Apr 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 10th Apr 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 09th Apr 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 18th Jan 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
